Background: Impaired low-contrast visual acuity (LCVA) is common in multiple sclerosis (MS) and
other neurological diseases. Its assessment is often limited to selected contrasts, for example, 2.5% or
1.25%. Computerized adaptive testing with the quick contrast-sensitivity function (qCSF) method allows
assessment across expanded contrast and spatial frequency ranges.
Objective: The objective of this article is to compare qCSF with high- and low-contrast charts and
patient-reported visual function.
Methods: We enrolled 131 consecutive MS patients (mean age 39.6 years) to assess high-contrast visual
acuity (HCVA) at 30 cm and 5 m, low-contrast vision with Sloan charts at 2.5% and 1.25%, qCSF and
the National Eye Institute Visual Functioning Questionnaire (NEIVFQ). Associations between the different
measures were estimated with linear regression models corrected for age, gender and multiple
testing.
Results: The association between qCSF and Sloan charts (R2¼0.68) was higher than with HCVA (5 m:
R2¼0.5; 30 cm: R2¼0.41). The highest association with NEIVFQ subscales was observed for qCSF (R2
0.20 0.57), while Sloan charts were not associated with any NEIVFQ subscale after correction for
multiple testing.
Conclusion: The qCSF is a promising new outcome for low-contrast vision in MS and other neurological
diseases. Here we show a closer link to patient-reported visual function than standard low- and
high-contrast charts.
«
Background: Impaired low-contrast visual acuity (LCVA) is common in multiple sclerosis (MS) and
other neurological diseases. Its assessment is often limited to selected contrasts, for example, 2.5% or
1.25%. Computerized adaptive testing with the quick contrast-sensitivity function (qCSF) method allows
assessment across expanded contrast and spatial frequency ranges.
Objective: The objective of this article is to compare qCSF with high- and low-contrast charts and
patient-reported visual fu...
»